Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCRLCharles River Laboratories
FinDog View：Neutral
| Metric | ABBV | CRL |
|---|
| Close | 262.51 | 273.41 |
| Market Cap | $464B | $13.1B |
| 1M | +4.87% | −4.62% |
| P/E (TTM) | 73.7 | — |
| Forward P/E | 16.8 | 24.2 |
| P/E 5-Yr Percentile | 51 | — |
| P/S | 7.2 | 3.3 |
| P/B | — | 4.6 |
| Dividend Yield | 4.47% | — |
| Latest Quarter Revenue | $17.0B | $1.0B |
| Revenue YoY | +10.2% | −2.7% |
| Gross Margin | 74.7% | — |
| Latest Quarter EPS | 2.03 | -0.03 |
| Avg Post-Earnings Move | ±1.7% | ±1.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 2.48% |
| 90-Day Net Insider Buying | −$8.2M | −$42.6M |
ABBV · Revenue, Last 8 Quarters ($B)
CRL · Revenue, Last 8 Quarters ($B)
